Akihito Suzuki
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment 38
- Bipolar Disorder and Treatment 29
- Epilepsy research and treatment 14
- Pharmacology top 0.5%
- Treatment of Major Depression 20
- Pharmacogenetics and Drug Metabolism 16
- Biological Psychiatry top 5%
- Behavioral Neuroscience top 5%
-
- Neurotransmitter Receptor Influence on Behavior 18
-
- Child and Adolescent Psychosocial and Emotional Development 20
-
- Pharmacological Effects and Toxicity Studies 12
- Co-authors
- Koichi OtaniKazuo MiharaTsuyoshi KondoSunao KanekoYoshihiko MatsumotoNorio Yasui‐FurukoriK. OtaniTakashi Fukasawa
- Journals
- SHILAP Revista de lepidopterología (5 papers)American Journal of Psychiatry (1 paper)Journal of Affective Disorders (3 papers)
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
Akihito Suzuki
149 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 128
- Psychiatry and Mental health 900
- Pharmacology 441
- Biological Psychiatry 106
- Behavioral Neuroscience 94
- Cellular and Molecular Neuroscience 379
Countries citing papers authored by Akihito Suzuki
This map shows the geographic impact of Akihito Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihito Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihito Suzuki more than expected).
Fields of papers citing papers by Akihito Suzuki
This network shows the impact of papers produced by Akihito Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihito Suzuki. The network helps show where Akihito Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akihito Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 3 | |
| 12 | Interrelation Between Increased BDNF Gene Methylation and High Sociotropy, a Personality Vulnerability Factor in Cognitive Model of Depression | 2020 | 1 |
| 13 | 2018 | 4 | |
| 14 | 2011 | 17 | |
| 15 | 2009 | 21 | |
| 16 | 2005 | 67 | |
| 17 | 2004 | 49 | |
| 18 | 2002 | 45 | |
| 19 | 1998 | 1 | |
| 20 | Pharmacokinetics and metabolism of 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man. | 1979 | 21 |
About Akihito Suzuki
Akihito Suzuki is a scholar working on Psychiatry and Mental health, Aging and Pharmacology, having authored 156 papers that have together received 2.2k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (38 papers), Bipolar Disorder and Treatment (29 papers), Child and Adolescent Psychosocial and Emotional Development (20 papers), Treatment of Major Depression (20 papers), Neurotransmitter Receptor Influence on Behavior (18 papers), Pharmacogenetics and Drug Metabolism (16 papers), Epilepsy research and treatment (14 papers) and Pharmacological Effects and Toxicity Studies (12 papers). The work is most often cited by research in Psychiatry and Mental health (900 citations), Pharmacology (441 citations) and Biological Psychiatry (106 citations). Akihito Suzuki has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Koichi Otani, Kazuo Mihara, Tsuyoshi Kondo, Sunao Kaneko, Yoshihiko Matsumoto, Norio Yasui‐Furukori, K. Otani, Takashi Fukasawa, Yoshimasa Inoue and Mitsuhiro Kamata. Their work appears in journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.